Filing Details
- Accession Number:
- 0001209191-20-055046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 15:58:44
- Reporting Period:
- 2020-10-14
- Accepted Time:
- 2020-10-16 15:58:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1741830 | Kronos Bio Inc. | KRON | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1361712 | Otello Stampacchia | 888 Boylston St. Suite 1111 Boston MA 02199 | Yes | No | No | No | |
1641348 | Omega Fund V Gp Manager, Ltd. | 888 Boylston St. Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1641354 | Omega Fund V, L.p. | 888 Boylston St. Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1641355 | Omega Fund V Gp, L.p. | 888 Boylston St. Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1652863 | Anne-Mari Paster | 888 Boylston St. Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1722050 | Claudio Nessi | 888 Boylston St. Suite 1111 Boston MA 02199 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-10-14 | 1,606,220 | $0.00 | 1,625,671 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2020-10-14 | 1,376,313 | $0.00 | 3,001,984 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2020-10-14 | 366,299 | $16.15 | 3,368,283 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2020-10-14 | 450,000 | $19.00 | 3,818,283 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series Seed Preferred Stock | Disposition | 2020-10-14 | 1,522,484 | $0.00 | 1,606,220 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2020-10-14 | 1,304,563 | $0.00 | 1,376,313 | $0.00 |
Common Stock | Convertible Promissory Note | Disposition | 2020-10-14 | 0 | $0.00 | 366,299 | $16.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | 2022-02-20 | No | 4 | C | Direct |
Footnotes
- Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- Otello Stampacchia, a director of the Issuer, Claudio Nessi and Anne-Mari Paster are the directors of Omega Fund V GP Manager, Ltd. ("Omega Manager"), which is the sole general partner of Omega V Fund GP, L.P. ("Omega GP"), which is the sole general partner of Omega Fund V, L.P. ("Omega L.P."). Such individuals may be deemed to share voting and dispositive power over the shares held by Omega L.P. Such individuals, together with Omega GP and Omega Manager, disclaim beneficial ownership of the shares held by Omega L.P. except to the extent of their respective pecuniary interests therein.
- The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.